Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven T Rosen

Showing results (11-20 of 214) with videos related to

Pageof 22
Sort By:
Seminars in Oncology|February 1, 2017
Conceptual aspects of combining rituximab and Campath-1H in the treatment of chronic lymphocytic leukemiaChadi Nabhan, Steven T Rosen
Seminars in Oncology|February 14, 2002
Conceptual aspects of combining rituximab and Campath-1H in the treatment of chronic lymphocytic leukemiaChadi Nabhan, Steven T Rosen
Oncology (Williston Park, N.Y.)|November 29, 2013
Peripheral T-cell lymphoma: new therapeutic strategiesAdam M Petrich, Steven T Rosen
Cancer Treatment and Research|January 1, 2019
Primary Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sezary SyndromeChristiane Querfeld, Jasmine Zain, Steven T Rosen
Oncology (Williston Park, N.Y.)|August 20, 2014
Cardiovascular toxicity of biologic agents for cancer therapyManali Bhave, Nausheen Akhter, Steven T Rosen
Current Opinion in Oncology|July 19, 2021
Targeting SUMOylation in cancerLi Du, Wei Liu, Steven T Rosen
Oncology (Williston Park, N.Y.)|April 17, 2016
Clinical Management Updates in Mantle Cell LymphomaRobert Chen, James Sanchez, Steven T Rosen
Current Opinion in Oncology|July 14, 2020
Targeting microRNA in hematologic malignanciesZhen Han, Steven T Rosen, Christiane Querfeld
Current Opinion in Oncology|August 24, 2012
Glucose transporters in cancer metabolismKehinde Adekola, Steven T Rosen, Mala Shanmugam
Current Opinion in Oncology|July 10, 2009
Targeting the Warburg effect in hematological malignancies: from PET to therapyMala Shanmugam, Samuel K McBrayer, Steven T Rosen
Pageof 22

Showing results (11-20 of 214) with videos related to

Sort By:
Pageof 22
Seminars in Oncology|February 1, 2017
Conceptual aspects of combining rituximab and Campath-1H in the treatment of chronic lymphocytic leukemiaChadi Nabhan, Steven T Rosen
Seminars in Oncology|February 14, 2002
Conceptual aspects of combining rituximab and Campath-1H in the treatment of chronic lymphocytic leukemiaChadi Nabhan, Steven T Rosen
Oncology (Williston Park, N.Y.)|November 29, 2013
Peripheral T-cell lymphoma: new therapeutic strategiesAdam M Petrich, Steven T Rosen
Cancer Treatment and Research|January 1, 2019
Primary Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sezary SyndromeChristiane Querfeld, Jasmine Zain, Steven T Rosen
Oncology (Williston Park, N.Y.)|August 20, 2014
Cardiovascular toxicity of biologic agents for cancer therapyManali Bhave, Nausheen Akhter, Steven T Rosen
Current Opinion in Oncology|July 19, 2021
Targeting SUMOylation in cancerLi Du, Wei Liu, Steven T Rosen
Oncology (Williston Park, N.Y.)|April 17, 2016
Clinical Management Updates in Mantle Cell LymphomaRobert Chen, James Sanchez, Steven T Rosen
Current Opinion in Oncology|July 14, 2020
Targeting microRNA in hematologic malignanciesZhen Han, Steven T Rosen, Christiane Querfeld
Current Opinion in Oncology|August 24, 2012
Glucose transporters in cancer metabolismKehinde Adekola, Steven T Rosen, Mala Shanmugam
Current Opinion in Oncology|July 10, 2009
Targeting the Warburg effect in hematological malignancies: from PET to therapyMala Shanmugam, Samuel K McBrayer, Steven T Rosen
Pageof 22